Shree Ganesh Remedies Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002863,
    "name": "Shree Ganesh Rem",
    "stock_name": "Shree Ganesh Rem",
    "full_name": "Shree Ganesh Remedies Ltd",
    "name_url": "stocks-analysis/shree-ganesh-rem",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "475.20",
    "chg": 2.25,
    "chgp": "0.48%",
    "dir": 1,
    "prev_price": "472.95",
    "mcapval": "592.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540737,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE414Y01015",
    "curr_date": "Apr 06",
    "curr_time": "",
    "bse_nse_vol": "2.55 k",
    "exc_status": "Active",
    "traded_date": "Apr 06, 2026",
    "traded_date_str": "2026 04 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shree-ganesh-rem-1002863-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Shree Ganesh Remedies Ltd Valuation Shifts Signal Elevated Price Risk",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-ltd-valuation-shifts-signal-elevated-price-risk-3933706",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShreeGaneshReme_valuationdot_3933706.png",
        "date": "2026-04-06 08:01:30",
        "description": "Shree Ganesh Remedies Ltd has seen a notable shift in its valuation parameters, moving from a fair to an expensive rating, driven primarily by its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This change contrasts with its historical valuation and peer group metrics, raising questions about the stock's price attractiveness in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Shree Ganesh Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shree-ganesh-remedies-ltd-is-rated-strong-sell-3928195",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShreeGaneshReme_mojoScore_3928195.png",
        "date": "2026-04-01 10:10:44",
        "description": "Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Shree Ganesh Remedies Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-ltd-faces-bearish-momentum-amid-technical-downgrade-3923453",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShreeGaneshReme_technicaldot_3923453.png",
        "date": "2026-03-30 08:02:47",
        "description": "Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a marked shift in technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action and technical parameters suggest increasing downside pressure, raising concerns for investors amid a challenging market backdrop."
      },
      {
        "title": "Shree Ganesh Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-ltd-valuation-shifts-signal-renewed-price-attractiveness-3909104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShreeGaneshReme_valuationdot_3909104.png",
        "date": "2026-03-24 08:02:00",
        "description": "Shree Ganesh Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade amid a challenging market backdrop. Despite a recent downgrade to a Strong Sell rating, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a recalibration of investor expectations, warranting a closer examination of its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Shree Ganesh Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shree-ganesh-remedies-ltd-is-rated-strong-sell-3904809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShreeGaneshReme_mojoScore_3904809.png",
        "date": "2026-03-21 10:10:36",
        "description": "Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Shree Ganesh Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shree-ganesh-remedies-ltd-is-rated-strong-sell-3882299",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ShreeGaneshReme_mojoScore_3882299.png",
        "date": "2026-03-10 10:10:50",
        "description": "Shree Ganesh Remedies Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Shree Ganesh Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shree-ganesh-remedies-ltd-is-rated-strong-sell-3857669",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShreeGaneshReme_mojoScore_3857669.png",
        "date": "2026-02-26 10:11:18",
        "description": "Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Shree Ganesh Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shree-ganesh-remedies-ltd-is-rated-strong-sell-3840761",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShreeGaneshReme_mojoScore_3840761.png",
        "date": "2026-02-15 10:10:45",
        "description": "Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Shree Ganesh Remedies Ltd Valuation Shifts Signal Price Attractiveness Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-ltd-valuation-shifts-signal-price-attractiveness-decline-3827914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ShreeGaneshReme_valuationdot_3827914.png",
        "date": "2026-02-09 08:02:37",
        "description": "Shree Ganesh Remedies Ltd has seen a notable shift in its valuation parameters, moving from fair to expensive territory, as reflected in its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. Despite a recent uptick in share price, the company’s valuation now stands out against both historical averages and peer benchmarks, raising questions about price attractiveness amid mixed financial performance and market returns."
      }
    ],
    "total": 537,
    "sid": "1002863",
    "stock_news_url": "https://www.marketsmojo.com/news/shree-ganesh-remedies-1002863"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "21-Mar-2026",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Mar-2026",
      "details": "Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Notice Of Extraordinary General Meeting",
      "datetime": "13-Mar-2026",
      "details": "Notice of Extraordinary General Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Remedies Ltd has declared <strong>5%</strong> dividend, ex-date: 07 Sep 23",
          "dt": "2023-09-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Remedies Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 01 Nov 21",
          "dt": "2021-11-01",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Remedies Ltd has announced <strong>7:100</strong> rights issue, ex-date: 03 Feb 23",
          "dt": "2023-02-03",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Shree Ganesh Remedies Ltd Valuation Shifts Signal Elevated Price Risk

2026-04-06 08:01:30

Shree Ganesh Remedies Ltd has seen a notable shift in its valuation parameters, moving from a fair to an expensive rating, driven primarily by its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This change contrasts with its historical valuation and peer group metrics, raising questions about the stock's price attractiveness in the Pharmaceuticals & Biotechnology sector.

Read full news article

Shree Ganesh Remedies Ltd is Rated Strong Sell

2026-04-01 10:10:44

Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Shree Ganesh Remedies Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-03-30 08:02:47

Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a marked shift in technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action and technical parameters suggest increasing downside pressure, raising concerns for investors amid a challenging market backdrop.

Read full news article

Shree Ganesh Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-03-24 08:02:00

Shree Ganesh Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade amid a challenging market backdrop. Despite a recent downgrade to a Strong Sell rating, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a recalibration of investor expectations, warranting a closer examination of its price attractiveness relative to peers and historical benchmarks.

Read full news article

Shree Ganesh Remedies Ltd is Rated Strong Sell

2026-03-21 10:10:36

Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Shree Ganesh Remedies Ltd is Rated Strong Sell

2026-03-10 10:10:50

Shree Ganesh Remedies Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Shree Ganesh Remedies Ltd is Rated Strong Sell

2026-02-26 10:11:18

Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Shree Ganesh Remedies Ltd is Rated Strong Sell

2026-02-15 10:10:45

Shree Ganesh Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Shree Ganesh Remedies Ltd Valuation Shifts Signal Price Attractiveness Decline

2026-02-09 08:02:37

Shree Ganesh Remedies Ltd has seen a notable shift in its valuation parameters, moving from fair to expensive territory, as reflected in its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. Despite a recent uptick in share price, the company’s valuation now stands out against both historical averages and peer benchmarks, raising questions about price attractiveness amid mixed financial performance and market returns.

Read full news article

View All News